NCT01259999

Brief Summary

Dietary intake in frail elderly is often lower than estimated needs due to the combined effects of the anorexia of ageing, frailty and the presence of acute and chronic disease. The objectives of the present study are to assess the effects of an oleic acid rich formula fortified with micronutrients on energy intake, vitamin- and mineral status, muscle strength and mobility. The investigators have recently performed a similar study in an acute ward setting without micronutrients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 15, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

July 1, 2011

Status Verified

June 1, 2011

Enrollment Period

10 months

First QC Date

December 14, 2010

Last Update Submit

June 30, 2011

Conditions

Keywords

malnutritionoleic-acidmicronutrient supplementold peoples home

Outcome Measures

Primary Outcomes (1)

  • Increased intake of energy and nutrients

    The sample size has been estimated upon a minimum difference in daily energy intake between the Control and Calogen group of 200 kcal (4). To detect a significant difference in energy intake at the 5% significance level and with 80% power 27 subjects in each group were needed. To allow for study drop-outs this is increased to 30 subjects in each group.

    6 weeks as intervention 6 weeks as control

Secondary Outcomes (1)

  • Increased appetite

    6 weeks intervention 6 weeks control

Study Arms (1)

Energy dense formula

EXPERIMENTAL
Dietary Supplement: Calogen extra strawberry

Interventions

Calogen extra strawberryDIETARY_SUPPLEMENT

A daily dose of 3 x 30 ml Calogen extra strawberry flavour will be distributed at the same time as the medicines i.e. at 8.00, 12.00 and 20.00.

Also known as: Nutricia PDS:1005912
Energy dense formula

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • \>65 years old
  • Mini nutritional assessment-short form (MNA-SF)score \< 12 points
  • able to give informed consent.

You may not qualify if:

  • pancreatitis
  • fat malabsorption, non-consent for participation.
  • Subjects that have Calogen will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep of Geriatrics, Karolinska University Hospital

Stockholm, 141 86, Sweden

Location

Related Publications (1)

  • Tylner S, Cederholm T, Faxen-Irving G. Effects on Weight, Blood Lipids, Serum Fatty Acid Profile and Coagulation by an Energy-Dense Formula to Older Care Residents: A Randomized Controlled Crossover Trial. J Am Med Dir Assoc. 2016 Mar 1;17(3):275.e5-11. doi: 10.1016/j.jamda.2015.12.005. Epub 2016 Jan 23.

MeSH Terms

Conditions

Protein-Energy MalnutritionAnorexiaBody Weight ChangesMalnutrition

Condition Hierarchy (Ancestors)

Protein DeficiencyDeficiency DiseasesNutrition DisordersNutritional and Metabolic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight

Study Officials

  • Gerd Faxen Irving, RD, PHD

    Karolinska University Hospital Huddinge/NVS/KI

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 14, 2010

First Posted

December 15, 2010

Study Start

April 1, 2010

Primary Completion

February 1, 2011

Study Completion

May 1, 2011

Last Updated

July 1, 2011

Record last verified: 2011-06

Locations